Sean Laaman
Stock Analyst at Morgan Stanley
(4.83)
# 442
Out of 4,704 analysts
590
Total ratings
66.8%
Success rate
16.9%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Rated: Buy | $124 | $66.53 | +86.38% | 10 | Sep 1, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,230 → $1,250 | $1,033.15 | +20.99% | 13 | Sep 1, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $283 → $322 | $246.81 | +30.46% | 18 | Aug 26, 2026 | |
| ACAD ACADIA Pharmaceuticals | Rated: Hold | $27 → $28 | $28.02 | -0.07% | 14 | Aug 25, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Hold | $182 | $155.64 | +16.94% | 21 | Aug 24, 2026 | |
| ALEC Alector | Rated: Sell | $2 | $2.46 | -18.70% | 6 | Aug 17, 2026 | |
| IRON Disc Medicine | Rated: Buy | $85 → $90 | $79.23 | +13.59% | 13 | Aug 17, 2026 | |
| CGEM Cullinan Therapeutics | Rated: Buy | $30 | $22.09 | +35.81% | 10 | Aug 17, 2026 | |
| RXRX Recursion Pharmaceuticals | Rated: Hold | $5.5 → $5.3 | $3.63 | +46.01% | 5 | Aug 17, 2026 | |
| ERAS Erasca | Rated: Hold | $21 | $16.19 | +29.71% | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 | $8.82 | +13.38% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $74.67 | +24.55% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $8.98 | +100.45% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $16 → $18 | $16.70 | +7.78% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $13.77 | +52.51% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $10.86 | +194.66% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $16.39 | +34.23% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $17 | $20.09 | -15.38% | 6 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $97 | $74.84 | +29.61% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $242 → $251 | $206.68 | +21.44% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $105 | $110.19 | -4.71% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $22.28 | +79.53% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $43 | $36.13 | +19.01% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 | $59.01 | -10.18% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $395 → $405 | $358.26 | +13.05% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.69 | n/a | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $7.94 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.80 → $3.95 | $4.66 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $228.35 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.70 | $31.39 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310.00 | $173.18 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.60 → $31.65 | $19.57 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.38 → $24.14 | $41.83 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26.37 → $28.35 | $44.30 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $276.00 → $256.00 | $140.39 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.30 | $0.46 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.15 → $7.35 | $6.63 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.45 → $1.65 | $0.82 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47.84 → $46.61 | $20.58 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53.60 → $51.60 | $53.22 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.70 → $2.75 | $2.33 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.93 | n/a | 2 | Aug 24, 2021 |
BioMarin Pharmaceutical
Sep 1, 2026
Rated: Buy
Price Target: $124
Current: $66.53
Upside: +86.38%
argenx SE
Sep 1, 2026
Rated: Buy
Price Target: $1,230 → $1,250
Current: $1,033.15
Upside: +20.99%
Jazz Pharmaceuticals
Aug 26, 2026
Rated: Buy
Price Target: $283 → $322
Current: $246.81
Upside: +30.46%
ACADIA Pharmaceuticals
Aug 25, 2026
Rated: Hold
Price Target: $27 → $28
Current: $28.02
Upside: -0.07%
Neurocrine Biosciences
Aug 24, 2026
Maintained: Hold
Price Target: $182
Current: $155.64
Upside: +16.94%
Alector
Aug 17, 2026
Rated: Sell
Price Target: $2
Current: $2.46
Upside: -18.70%
Disc Medicine
Aug 17, 2026
Rated: Buy
Price Target: $85 → $90
Current: $79.23
Upside: +13.59%
Cullinan Therapeutics
Aug 17, 2026
Rated: Buy
Price Target: $30
Current: $22.09
Upside: +35.81%
Recursion Pharmaceuticals
Aug 17, 2026
Rated: Hold
Price Target: $5.5 → $5.3
Current: $3.63
Upside: +46.01%
Erasca
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $16.19
Upside: +29.71%
Aug 17, 2026
Rated: Hold
Price Target: $10
Current: $8.82
Upside: +13.38%
Aug 17, 2026
Rated: Buy
Price Target: $93
Current: $74.67
Upside: +24.55%
Aug 17, 2026
Rated: Buy
Price Target: $18
Current: $8.98
Upside: +100.45%
Aug 17, 2026
Rated: Hold
Price Target: $16 → $18
Current: $16.70
Upside: +7.78%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $13.77
Upside: +52.51%
Aug 17, 2026
Rated: Buy
Price Target: $32
Current: $10.86
Upside: +194.66%
Aug 17, 2026
Rated: Buy
Price Target: $22
Current: $16.39
Upside: +34.23%
Aug 12, 2026
Rated: Hold
Price Target: $17
Current: $20.09
Upside: -15.38%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $97
Current: $74.84
Upside: +29.61%
Aug 10, 2026
Maintained: Hold
Price Target: $242 → $251
Current: $206.68
Upside: +21.44%
Aug 7, 2026
Rated: Buy
Price Target: $93 → $105
Current: $110.19
Upside: -4.71%
Aug 7, 2026
Rated: Buy
Price Target: $36 → $40
Current: $22.28
Upside: +79.53%
Aug 7, 2026
Maintained: Hold
Price Target: $40 → $43
Current: $36.13
Upside: +19.01%
Aug 6, 2026
Maintained: Hold
Price Target: $53
Current: $59.01
Upside: -10.18%
Aug 6, 2026
Maintained: Buy
Price Target: $395 → $405
Current: $358.26
Upside: +13.05%
Aug 28, 2025
Maintained: Buy
Price Target: $3.30
Current: $2.69
Upside: n/a
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $7.94
Upside: n/a
Feb 12, 2025
Maintained: Hold
Price Target: $3.80 → $3.95
Current: $4.66
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $228.35
Upside: n/a
Jun 24, 2024
Maintained: Buy
Price Target: $33.70
Current: $31.39
Upside: n/a
Jun 12, 2024
Maintained: Buy
Price Target: $310.00
Current: $173.18
Upside: n/a
May 22, 2024
Maintained: Buy
Price Target: $33.60 → $31.65
Current: $19.57
Upside: n/a
Apr 9, 2024
Maintained: Hold
Price Target: $25.38 → $24.14
Current: $41.83
Upside: n/a
Mar 22, 2024
Maintained: Hold
Price Target: $26.37 → $28.35
Current: $44.30
Upside: n/a
Mar 21, 2024
Maintained: Sell
Price Target: $276.00 → $256.00
Current: $140.39
Upside: n/a
Feb 28, 2024
Maintained: Sell
Price Target: $1.30
Current: $0.46
Upside: n/a
Feb 27, 2024
Maintained: Hold
Price Target: $8.15 → $7.35
Current: $6.63
Upside: n/a
Feb 26, 2024
Maintained: Buy
Price Target: $1.45 → $1.65
Current: $0.82
Upside: n/a
Jan 12, 2024
Maintained: Buy
Price Target: $47.84 → $46.61
Current: $20.58
Upside: n/a
Nov 28, 2023
Maintained: Hold
Price Target: $53.60 → $51.60
Current: $53.22
Upside: n/a
Aug 28, 2023
Maintained: Sell
Price Target: $2.70 → $2.75
Current: $2.33
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $13.93
Upside: n/a